Viridian Therapeutics Ors Inc (VRDN)
CapEx to Revenue
459.86%
Quarterly · Period ending:
VRDN CapEx to Revenue
Latest reported459.86%period ending
Latest reported459.86%period ending
VRDN Quarterly CapEx/Revenue (0.00% → 459.86%)
Latest values, visible window
High-resolution chart · PNG
VRDN capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 459.8592% | |
| 16.3121% | |
| 181.8182% | |
| 0.18% | |
| 56% | |
| 119.4444% | |
| 158.3333% | |
| 340.6977% | |
| 144.4444% | |
| 0% | |
| 66.6667% | |
| 561.1111% | |
| 459.7222% | |
| 117.3469% | |
| 220% | |
| 7.9498% | |
| 114.0625% | |
| 82.8704% | |
| 39.2523% | |
| 88.9423% | |
| 4.9541% | |
| 1.0338% | |
| 98.1481% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 2.1583% | |
| 1.2729% | |
| 9.9462% | |
| 10.7143% | |
| 21.7161% | |
| 4.308% | |
| 1.9858% | |
| 2.8523% | |
| 3.8627% | |
| 14.624% | |
| 9.5238% | |
| 1.3228% | |
| 2.6997% | |
| 12.7002% | |
| 0.3667% | |
| 3.4901% | |
| 6.3872% | |
| 3.2698% | |
| 6.8217% | |
| 39.9886% | |
| 0% | |
| 0% | |
| 0% | |
| 0.2405% | |
| 0.2182% | |
| 0% | |
| 0% |